Research & Development
A recent study investigated the metabolism of AMINOHEAL in human subjects, focusing on its effects on branched-chain amino acid (BCAA) levels. Researchers measured baseline BCAA levels before administering a single dose of AMINOHEAL. After 30 minutes, BCAA levels surged 2-5 times higher and remained elevated even after 3 hours. The study concluded that one dose of AMINOHEAL can elevate BCAA levels for up to 3 hours, making it a promising supplement for neurological health.
Read the full study here:
Setting the Stage for Branched-Chain Amino Acids Use in Neurological Pathologies: Does a Single Oral Dose Provide Hours of Elevated Systemic Levels?
Mathew, E., Jones, N., Dews, M., Neal, D., & Cohen, A. (2025). Diseases, 13(3), 76.
Ground-breaking Research on AMINOHEAL and Traumatic Brain Injury
Ground-breaking evidence from researchers using a proven murine model for traumatic brain injury (TBI) has demonstrated for the first time that TBI can be reduced and possibly entirely prevented with AMINOHEAL. This research played a key role in the United States government granting a patent for the prevention and reduction of TBI. The investigators found that animals receiving AMINOHEAL before and after TBI behaved as if they were uninjured, and post-mortem brain analysis showed little to no damage. Could this be the key to preventing CTE? Stay tuned—researchers are getting closer to answering this question.
Read the full study here